D. E. Shaw & Co., Inc. Glaukos Corp Transaction History

D. E. Shaw & Co., Inc.

$156 Billion
Q3 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Glaukos Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 278,435 shares of GKOS stock, worth $25.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

278,435

Holding current value

$25.1 Million

% of portfolio

0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$79.92 - $106.55 $22.3 Million - $29.7 Million	278,435 New	278,435 $22.7 Million
Q1 2025 May 15, 2025	SELL	$96.6 - $161.22 $57,960 - $96,732	-600 Reduced 22.21%	2,101 $206,000
Q4 2024 Feb 14, 2025	BUY	$126.42 - $152.67 $144,245 - $174,196	1,141 Added 73.14%	2,701 $404,000
Q3 2024 Nov 14, 2024	SELL	$113.62 - $135.39 $2.93 Million - $3.49 Million	-25,799 Reduced 94.3%	1,560 $203,000
Q2 2024 Aug 14, 2024	SELL	$89.48 - $118.35 $1.37 Million - $1.82 Million	-15,357 Reduced 35.95%	27,359 $3.24 Million
Q1 2024 May 15, 2024	SELL	$76.4 - $96.33 $17.7 Million - $22.3 Million	-231,516 Reduced 84.42%	42,716 $4.03 Million
Q4 2023 Feb 14, 2024	BUY	$59.53 - $85.11 $13.2 Million - $18.8 Million	221,131 Added 416.43%	274,232 $21.8 Million
Q3 2023 Nov 14, 2023	SELL	$69.23 - $79.09 $4.73 Million - $5.4 Million	-68,324 Reduced 56.27%	53,101 $4 Million
Q2 2023 Aug 14, 2023	BUY	$45.44 - $71.21 $1.04 Million - $1.63 Million	22,926 Added 23.28%	121,425 $8.65 Million
Q1 2023 May 15, 2023	BUY	$43.88 - $52.48 $2.13 Million - $2.55 Million	48,591 Added 97.36%	98,499 $4.93 Million
Q4 2022 Feb 14, 2023	BUY	$40.82 - $57.75 $1.52 Million - $2.15 Million	37,192 Added 292.48%	49,908 $2.18 Million
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $595,617 - $743,758	12,716 New	12,716 $677,000
Q1 2022 May 16, 2022	SELL	$44.33 - $57.82 $11.1 Million - $14.5 Million	-250,058 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$40.27 - $56.99 $6.42 Million - $9.08 Million	159,353 Added 175.68%	250,058 $11.1 Million
Q3 2021 Nov 15, 2021	BUY	$47.43 - $84.23 $4.3 Million - $7.64 Million	90,705 New	90,705 $4.37 Million
Q3 2020 Nov 16, 2020	SELL	$37.23 - $50.97 $3.12 Million - $4.27 Million	-83,801 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$28.78 - $46.83 $2.14 Million - $3.49 Million	74,501 Added 801.09%	83,801 $3.22 Million
Q1 2020 May 15, 2020	BUY	$25.53 - $70.14 $51,749 - $142,173	2,027 Added 27.87%	9,300 $287,000
Q4 2019 Feb 14, 2020	SELL	$54.18 - $65.64 $1.36 Million - $1.65 Million	-25,089 Reduced 77.53%	7,273 $396,000
Q3 2019 Nov 14, 2019	SELL	$58.58 - $83.91 $3.22 Million - $4.61 Million	-54,915 Reduced 62.92%	32,362 $2.02 Million
Q2 2019 Aug 14, 2019	SELL	$63.59 - $78.71 $7.6 Million - $9.41 Million	-119,593 Reduced 57.81%	87,277 $6.58 Million
Q1 2019 May 15, 2019	BUY	$50.75 - $80.54 $5.68 Million - $9.02 Million	111,932 Added 117.9%	206,870 $16.2 Million
Q4 2018 Feb 14, 2019	SELL	$52.18 - $67.93 $8.86 Million - $11.5 Million	-169,799 Reduced 64.14%	94,938 $5.33 Million
Q3 2018 Nov 14, 2018	BUY	$38.13 - $68.37 $10.1 Million - $18.1 Million	264,737 New	264,737 $17.2 Million

Others Institutions Holding GKOS

# of Institutions

349

Shares Held

55.3M

Call Options Held

163K

Put Options Held

458K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $4.29B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account